Foundation or philanthropic investor
Johnson & Johnson Impact Ventures
Johnson & Johnson Impact Ventures (J&J Impact Ventures) is an impact investment fund operating within the Johnson & Johnson Foundation. It was launched in 2019 with a $50 million commitment, aiming to accelerate access to affordable, quality healthcare globally. The fund invests in a portfolio of impact startups and partnerships across various healthcare sub-sectors, including health systems and supply chain, healthtech and digital platforms, medtech and diagnostics, and care delivery and clinical services. A distinguishing feature of J&J Impact Ventures is its "more than capital" approach, which leverages Johnson & Johnson's extensive network, expertise, and resources to provide strategic direction and operational support to its portfolio companies. Financial returns from successful investments are reinvested in new investments to ensure the sustainability and expansion of their impact. J&J Impact Ventures also supports the broader health impact investing ecosystem by funding early-stage entrepreneurs, developing common metrics for impact measurement, and advocating for greater investment in health equity.
Investment focus
- Sectors
- HealthcareTechnology
- Stages and strategies
- SeedFund investments
- Regions
- Northern Africa, Eastern Africa, Western Africa, Central Africa, Southern Africa
Fund commitments
Selected portfolio and direct investments
- Rology Inc
Recent investments and transactions
| Date | Transaction | Type | Value | Market |
|---|---|---|---|---|
| 1 Dec 2025 | Philips Foundation, Johnson & Johnson Impact Ventures, Sanofi Global Health Unit’s Impact Fund & MIT Solve Innovation Future's investment in Rology's operations in MEA | Venture Capital | Undisclosed | Egypt |
Sources
- Partner Researchers, accessed 14 November 2026
- https://www.jnj.com/impact-ventures/j-j-impact-ventures-invests-in-verge-healthtech-fund-to-accelerate-early-stage-impact-innovations-globally, www.jnj.com. Accessed 14 November 2026.